Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Serotype I
RefBlack FT. Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl. Microbiol. 25: 528-533, 1973. PubMed: 4572983
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 2616: Ureaplasma Medium - Special Modified Formulation
Growth Conditions
Temperature: 37°C
Atmosphere: Broth: Aerobic; Plates: Anaerobic
Name of Depositor
MC Shepard
Chain of Custody
ATCC <-- MC Shepard <-- F. Black 7 <-- D. Ford 7
References
Black FT. Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl. Microbiol. 25: 528-533, 1973. PubMed: 4572983
Shepard MC, et al. Ureaplasma urealyticum gen. nov., sp. nov.: Proposed nomenclature for the human T (T-strain) Mycoplasmas. Int. J. Syst. Bacteriol. 24: 160-171, 1974.
Robertson JA, et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int. J. Syst. Evol. Microbiol. 52: 587-597, 2002. PubMed: 11931172
Black FT. Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl. Microbiol. 25: 528-533, 1973. PubMed: 4572983
Black FT. Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl. Microbiol. 25: 528-533, 1973. PubMed: 4572983